Search research articles
Contact Us
Filters
Showing results (41-50 of 176) with videos related to
Page
of 18
Sort By:
Clinical Genitourinary Cancer
|
November 15, 2013
The effect of targeted therapy on overall survival in advanced renal cancer: a study of the national surveillance epidemiology and end results registry database
Ulka Vaishampayan, Hema Vankayala, Fawn D Vigneau, et al.
Research Square
|
March 3, 2023
Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth
Barani Govindarajan, Diego Sbrissa, Mark Pressprich, et al.
Investigational New Drugs
|
October 31, 2003
A phase II study of rebeccamycin analog (NSC-655649) in metastatic renal cell cancer
Maha Hussain, Ulka Vaishampayan, Lance K Heilbrun, et al.
Anti-Cancer Drugs
|
July 30, 2011
Safety and efficacy of molecularly targeted agents in patients with metastatic kidney cancer with renal dysfunction
Sachin Gupta, Venkata Parsa, Lance K Heilbrun, et al.
Expert Review of Anticancer Therapy
|
November 15, 2013
Sequencing therapy in advanced prostate cancer: focus on sipuleucel-T
David I Quinn, Ulka Vaishampayan, Celestia S Higano, et al.
European Urology Focus
|
May 20, 2019
Considerations for the Next Clinical Trial Evaluating the Role of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
Hyung L Kim, Eddie Mayerson, Primo N Lara, et al.
Investigational New Drugs
|
July 8, 2010
Cediranib in combination with various anticancer regimens: results of a phase I multi-cohort study
Patricia Lorusso, Anthony F Shields, Shirish Gadgeel, et al.
American Journal of Translational Research
|
August 25, 2010
A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer
Elisabeth I Heath, Lance K Heilbrun, Jing Li, et al.
Clinical Genitourinary Cancer
|
April 8, 2016
Radium-223 in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer
Dipenkumar Modi, Clara Hwang, Hirva Mamdani, et al.
Urology
|
August 12, 2008
Phase II trial of capecitabine and weekly docetaxel in metastatic renal cell carcinoma
Shanthi Marur, James Eliason, Lance K Heilbrun, et al.
Page
of 18
Search research articles
Search
Showing results (41-50 of 176) with videos related to
Sort By:
Page
of 18
Clinical Genitourinary Cancer
|
November 15, 2013
The effect of targeted therapy on overall survival in advanced renal cancer: a study of the national surveillance epidemiology and end results registry database
Ulka Vaishampayan, Hema Vankayala, Fawn D Vigneau, et al.
Research Square
|
March 3, 2023
Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth
Barani Govindarajan, Diego Sbrissa, Mark Pressprich, et al.
Investigational New Drugs
|
October 31, 2003
A phase II study of rebeccamycin analog (NSC-655649) in metastatic renal cell cancer
Maha Hussain, Ulka Vaishampayan, Lance K Heilbrun, et al.
Anti-Cancer Drugs
|
July 30, 2011
Safety and efficacy of molecularly targeted agents in patients with metastatic kidney cancer with renal dysfunction
Sachin Gupta, Venkata Parsa, Lance K Heilbrun, et al.
Expert Review of Anticancer Therapy
|
November 15, 2013
Sequencing therapy in advanced prostate cancer: focus on sipuleucel-T
David I Quinn, Ulka Vaishampayan, Celestia S Higano, et al.
European Urology Focus
|
May 20, 2019
Considerations for the Next Clinical Trial Evaluating the Role of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
Hyung L Kim, Eddie Mayerson, Primo N Lara, et al.
Investigational New Drugs
|
July 8, 2010
Cediranib in combination with various anticancer regimens: results of a phase I multi-cohort study
Patricia Lorusso, Anthony F Shields, Shirish Gadgeel, et al.
American Journal of Translational Research
|
August 25, 2010
A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer
Elisabeth I Heath, Lance K Heilbrun, Jing Li, et al.
Clinical Genitourinary Cancer
|
April 8, 2016
Radium-223 in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer
Dipenkumar Modi, Clara Hwang, Hirva Mamdani, et al.
Urology
|
August 12, 2008
Phase II trial of capecitabine and weekly docetaxel in metastatic renal cell carcinoma
Shanthi Marur, James Eliason, Lance K Heilbrun, et al.
Page
of 18